Melanoma: all 3,073 studies
Page 5 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot StudyEnrolling by invitationNCT05223218
- Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)RecruitingNCT05196087
- Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell CarcinomaRecruitingNCT05155033Phase 2
- RAPA-201 Therapy of Solid TumorsRecruitingNCT05144698Phase 1/2
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyRecruitingNCT05136196Phase 2
- A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)RecruitingNCT05135715Phase 2
- To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced MelanomaRecruitingNCT05106023Phase 2
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerRecruitingNCT05098210Phase 1
- A Beta-only IL-2 ImmunoTherapY StudyRecruitingNCT05086692Phase 1/2
- A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal MelanomaRecruitingNCT05077280Phase 2
- A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint TherapyRecruitingNCT05077137Phase 1
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsRecruitingNCT05076760Phase 1
- iToBoS: Clinical Data Acquisition StudyNot yet recruitingNCT05075356Not applicable
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruitingNCT05059444
- High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver MalignanciesRecruitingNCT05053555Not applicable
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsRecruitingNCT05039801Phase 1
- The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid TumorsRecruitingNCT05037825
- Implementation of Teledermoscopy and Artificial IntelligenceRecruitingNCT05033678
- Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma PatientsRecruitingNCT05029791Not applicable
- Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System MetastasesRecruitingNCT05026983Phase 2
- Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMMRecruitingNCT05009446Early Phase 1
- Dermoscopy Augmented Histology Trial, a Randomized Controlled TrialNot yet recruitingNCT05004792Not applicable
- Using QPOP to Predict Treatment for Sarcomas and MelanomasRecruitingNCT04986748
- Irradiation of Melanoma in a PulseRecruitingNCT04986696Not applicable
- A Cohort IND Expanded Access Program for Supporting Patient Access to TebentafuspAvailableNCT04960891
- A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsRecruitingNCT04913285Phase 1
- Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic MelanomaRecruitingNCT04903119Phase 1
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain MetastasesRecruitingNCT04899908Phase 2
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 1
- A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsRecruitingNCT04895709Phase 1/2
- Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic SurgeryRecruitingNCT04879654Phase 2
- Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid TumoursRecruitingNCT04855435Phase 1
- IFx-Hu2.0 Expanded Access ProgramAvailableNCT04853602
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruitingNCT04851119Phase 1/2
- Community Based Strategies for Early Detection of MelanomaNot yet recruitingNCT04799106
- Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma MetastasesRecruitingNCT04793737Not applicable
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeRecruitingNCT04792463
- Quality of Life, Lifestyle, and Psychosocial Factors in Patients With MelanomaRecruitingNCT04778449
- Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsRecruitingNCT04771520Phase 2
- BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)RecruitingNCT04752826Phase 1/2
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruitingNCT04751396
- Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaRecruitingNCT04741997Early Phase 1
- MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck CancerRecruitingNCT04729543Phase 1/2
- Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATERecruitingNCT04720768Phase 1/2
- Intralesional Influenza Vaccine for the Treatment of Stage I-IV MelanomaRecruitingNCT04697576Phase 1
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialRecruitingNCT04693377Not applicable
- Evolution of Metabolic and Immune Dysfunction in In-transit MelanomaRecruitingNCT04658303
- OH2 Injection in Combination With HX008 for Melanoma.RecruitingNCT04616443Phase 1/2
- Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab MonotherapyRecruitingNCT04605146Not applicable
- Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant MelanomaRecruitingNCT04598009Phase 2
- Nodal Radiation Therapy for Sentinel Lymph Node Positive MelanomaRecruitingNCT04594187Phase 2
- Immune Profiles Evolution Under Immunotherapy for MelanomaRecruitingNCT04576429Not applicable
- A Storage Facility for Tissues Obtained From Patients With Malignant MelanomaRecruitingNCT04567706
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAvailableNCT04566393
- Imatinib Mesylate in Combination With Pembrolizumab in Patients With MelanomaRecruitingNCT04546074Phase 1/2
- Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV MelanomaRecruitingNCT04513028Not applicable
- A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain MetastasesRecruitingNCT04511013Phase 2
- Serial Tumour Biopsies and Blood Biomarkers in MelanomaRecruitingNCT04493723
- Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?Not yet recruitingNCT04477876
- Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicRecruitingNCT04474301
- Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II StudyRecruitingNCT04462965Phase 2
- A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT04370587Phase 1/2
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
- Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral MelanomaRecruitingNCT04331093Phase 2
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesRecruitingNCT04282044Phase 1
- PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under ImmunotherapyRecruitingNCT04272658
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RecruitingNCT04198766Phase 1/2
- POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint InhibitorsRecruitingNCT04193956
- A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 MelanomaRecruitingNCT04126876Phase 2
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsRecruitingNCT04119024Phase 1
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesRecruitingNCT04114136Phase 2
- Registry of Subjects at Risk of Pancreatic CancerRecruitingNCT04095195
- Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma TreatmentRecruitingNCT04045691
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsRecruitingNCT04038619Phase 1
- Intratumoral Injection of PV-001-DV Plus DC in Patients With MelanomaNot yet recruitingNCT03990493Phase 1
- Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With MelanomaNot yet recruitingNCT03989895Phase 1
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsRecruitingNCT03947385Phase 1/2
- Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaRecruitingNCT03941756Not applicable
- Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 TherapyRecruitingNCT03888950Not applicable
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous MelanomaRecruitingNCT03860883Not applicable
- Neoadjuvant Combination Immunotherapy for Stage III MelanomaRecruitingNCT03842943Phase 2
- A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and LymphomaRecruitingNCT03829254Phase 1/2
- Observational Study of Iris TumorsRecruitingNCT03809585
- Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With MelanomaNot yet recruitingNCT03803397Phase 1
- Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsRecruitingNCT03755739Phase 2/3
- Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic MelanomaRecruitingNCT03743298Phase 1
- Genomic Investigation of Unusual RespondersRecruitingNCT03740503
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsRecruitingNCT03686124Phase 1/2
- Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb PerfusionRecruitingNCT03685890Phase 1/2
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma PatientsRecruitingNCT03567889Phase 3
- Melanoma Metastasized to the Brain and SteroidsRecruitingNCT03563729Phase 2
- Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsRecruitingNCT03454035Phase 1
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
- Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)RecruitingNCT03340129Phase 2
- French Clinical Datbase of Melanoma Patients (RIC-Mel)RecruitingNCT03315468
- Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma PatientsRecruitingNCT03166397Phase 2
- A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk MelanomaRecruitingNCT03116412Not applicable
- Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary MetastasesRecruitingNCT03093909Phase 1